Vioguard provides UV-C technology solutions designed to enhance infection control strategies. Its patented flagship product is a self-sanitizing automated keyboard and mouse system that uses germicidal UV-C, cleared by the U.S. Food and Drug Administration, which kills bacteria, viruses, fungi, and drug-resistant pathogens linked to hospital-acquired infections. The company holds multiple patents for sanitizing surfaces such as computer keyboards, touchscreens, telephones, escalator handrails, and writing implements. Additional product introductions expected include an escalator handrail sanitizer and a pen sterilizing device, both projected for release across 2017. The company intends to use new funding to expand sales and marketing and to broaden and accelerate product development initiatives. Founded in 2008 and led by President and CEO Laurance Ranta, Vioguard is based in Bothell, WA and has raised $11M in total funding to date.

Total raised

$5M

Funding rounds

1

Latest round

Series A

Latest activity

Jan 2017